Although this study showed the different KRAS status in RCC and LCC, and found the prognostic value of KRAS mutation was depending on the location of tumor, there were several limitations should be considered when interpreting the results. The gene discussed is KRAS; the disease is leukoencephalopathy with calcifications and cysts.